Citigroup
PASG icon

Citigroup’s Passage Bio PASG Stock Holding History

Citigroup’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-77
Closed -$617 – 6349
2025
Q3 		$617 Buy
+77
New +$536 ﹤0.01% 5687
2024
Q2 		– Sell
-198
Closed -$5.36K – 5727
2024
Q1 		$5.36K Sell
198
-42
-18% -$1.01K ﹤0.01% 5314
2023
Q4 		$4.85K Buy
+240
New +$3.31K ﹤0.01% 5339
2023
Q1 		– Sell
-10
Closed -$273 – 5760
2022
Q4 		$273 Sell
10
-33
-77% -$833 ﹤0.01% 5568
2022
Q3 		$1K Sell
43
-36
-46% -$1.42K ﹤0.01% 5663
2022
Q2 		$4K Sell
79
-1,975
-96% -$92.3K ﹤0.01% 5702
2022
Q1 		$127K Sell
2,054
-1,134
-36% -$93.5K ﹤0.01% 4307
2021
Q4 		$405K Buy
3,188
+433
+16% +$70.7K ﹤0.01% 3934
2021
Q3 		$549K Sell
2,755
-5,394
-66% -$1.29M ﹤0.01% 3543
2021
Q2 		$2.16M Buy
8,149
+2,477
+44% +$766K ﹤0.01% 2607
2021
Q1 		$1.98M Buy
5,672
+5,354
+1,684% +$2.29M ﹤0.01% 2497
2020
Q4 		$162K Buy
318
+272
+591% +$109K ﹤0.01% 5147
2020
Q3 		$12K Sell
46
-167
-78% -$57.5K ﹤0.01% 6507
2020
Q2 		$117K Buy
213
+157
+280% +$70.6K ﹤0.01% 5453
2020
Q1 		$18K Buy
+56
New +$17.5K ﹤0.01% 6760

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citigroup's PASG Position: Q4 2025 in Review

Citigroup sold out of Passage Bio (PASG) in Q4 2025, closing a stake of 77 shares — an estimated $617 sold.

Citigroup first reported a position in PASG in Q1 2020 and held it in 15 quarters. The position peaked at $2.16M in Q2 2021. 30 funds tracked by Wall St. Rank hold PASG as of Q4 2025.

  • Citigroup reported no remaining Passage Bio position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 77 Passage Bio shares in Q4 2025, an estimated $617.
  • Citigroup first reported a position in Passage Bio in Q1 2020 and held it in 15 quarters.
  • Citigroup's Passage Bio position peaked at $2.16M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.